Fig. 3 | Scientific Reports

Fig. 3

From: Multiomics Mendelian randomization integrating pQTL, eQTL and mQTL data revealed BTN3A2 as a potential drug target for nephrolithiasis

Fig. 3

Results of MR analyses assessing the causal association between PPRTs and nephrolithiasis complications. MR Mendelian randomization, FDR false discovery rate, BTN3A2 butyrophilin subfamily 3 member A2, ERBB4 receptor tyrosine-protein kinase erbB-4, UMOD uromodulin, PPRTs plasma protein-related targets, SNPs single-nucleotide polymorphisms. The P value threshold for FDR correction was 0.05.

Back to article page